Sale!

SPTB Gene Anemia Neonatal Hemolytic Fatal and Near-Fatal NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SPTB Gene Anemia Neonatal Hemolytic Fatal and Near-Fatal NGS Genetic DNA Test is a comprehensive genetic screening that identifies mutations in the SPTB gene responsible for hereditary spherocytosis. This advanced next-generation sequencing test detects genetic abnormalities that can cause severe hemolytic anemia in newborns, potentially leading to fatal or near-fatal outcomes. The test provides crucial information for early intervention, family planning, and personalized treatment strategies. Available for $500 USD, this specialized genetic analysis helps identify at-risk individuals and families, enabling proactive medical management and preventing life-threatening complications in newborns with inherited red blood cell disorders.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SPTB Gene Anemia Neonatal Hemolytic Fatal and Near-Fatal NGS Genetic DNA Test

Comprehensive Genetic Screening for Hereditary Spherocytosis

The SPTB Gene Anemia Neonatal Hemolytic Fatal and Near-Fatal NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for hereditary blood disorders. This specialized test utilizes cutting-edge Next-Generation Sequencing (NGS) technology to identify mutations in the SPTB gene, which encodes beta-spectrin – a critical protein component of the red blood cell membrane skeleton. When this gene malfunctions, it can lead to hereditary spherocytosis, a condition where red blood cells become spherical and fragile, causing severe hemolytic anemia that can be life-threatening in newborns.

What This Advanced Genetic Test Detects

Our comprehensive NGS genetic analysis specifically targets:

  • Pathogenic variants in the SPTB gene responsible for hereditary spherocytosis
  • Deletions, insertions, and point mutations affecting beta-spectrin production
  • Genetic markers associated with severe neonatal hemolytic anemia presentations
  • Inheritance patterns that may indicate fatal or near-fatal outcomes in newborns
  • Specific mutation types that correlate with disease severity and prognosis

Who Should Consider This Genetic Screening?

This specialized genetic test is recommended for individuals and families experiencing:

  • Newborns presenting with unexplained severe jaundice and anemia
  • Family history of hereditary spherocytosis or similar blood disorders
  • Previous pregnancies with fetal hydrops or severe hemolytic disease
  • Unexplained neonatal deaths with suspected hematological causes
  • Parents planning pregnancy with known family history of blood disorders
  • Infants requiring multiple blood transfusions in the neonatal period
  • Children with splenomegaly and chronic hemolytic anemia symptoms

Critical Benefits of Early Genetic Detection

Undergoing the SPTB Gene Anemia NGS Test provides numerous advantages:

  • Early Intervention Opportunities: Enables proactive medical management before severe complications develop
  • Family Planning Guidance: Provides crucial information for genetic counseling and reproductive decisions
  • Personalized Treatment Strategies: Allows for tailored therapeutic approaches based on specific genetic mutations
  • Prevention of Life-Threatening Events: Helps prevent fatal or near-fatal hemolytic crises in newborns
  • Comprehensive Risk Assessment: Identifies at-risk family members for proactive monitoring
  • Improved Long-Term Outcomes: Facilitates better management of chronic hemolytic anemia throughout life

Understanding Your Genetic Test Results

Our comprehensive genetic counseling support helps you interpret your results:

  • Positive Result: Indicates the presence of SPTB gene mutations associated with hereditary spherocytosis. This requires immediate consultation with a hematologist for management planning.
  • Negative Result: Suggests no detected mutations in the SPTB gene, though other genetic causes should be considered if clinical symptoms persist.
  • Variant of Uncertain Significance: Some genetic changes may require additional family studies to determine clinical relevance.
  • Carrier Status: Identifies individuals who carry one copy of the mutated gene and may pass it to offspring.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Accessibility

We proudly offer comprehensive genetic testing services across the United States, with specialized collection centers in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures that advanced genetic diagnostics are accessible to families nationwide.

Take Action for Your Family’s Health

Don’t wait for symptoms to appear. Early genetic detection can save lives and prevent serious complications. Our team of genetic counselors and hematology specialists are ready to guide you through the testing process and provide comprehensive support for your family’s health journey.

Book your SPTB Gene Anemia Neonatal Hemolytic Fatal and Near-Fatal NGS Genetic DNA Test today by calling our dedicated genetic counseling hotline at +1(267) 388-9828 or schedule your appointment online. Protect your family’s future with advanced genetic insights.